Masaji Okada

3.0k total citations · 1 hit paper
66 papers, 2.2k citations indexed

About

Masaji Okada is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Masaji Okada has authored 66 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Immunology, 24 papers in Infectious Diseases and 21 papers in Epidemiology. Recurrent topics in Masaji Okada's work include Tuberculosis Research and Epidemiology (24 papers), Mycobacterium research and diagnosis (20 papers) and Immunotherapy and Immune Responses (14 papers). Masaji Okada is often cited by papers focused on Tuberculosis Research and Epidemiology (24 papers), Mycobacterium research and diagnosis (20 papers) and Immunotherapy and Immune Responses (14 papers). Masaji Okada collaborates with scholars based in Japan, United States and France. Masaji Okada's co-authors include Tadamitsu Kishimoto, Masanori Kitahara, S. Kishimoto, Takao Hirano, Tadashi Matsuda, Gary R. Klimpel, Christopher S. Henney, Yoshikazu Inoue, Kazunari Tsuyuguchi and Katsuhiro Suzuki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Masaji Okada

62 papers receiving 2.1k citations

Hit Papers

Specific Detection of Tuberculosis Infection 2004 2026 2011 2018 2004 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Specific Detection of Tuberculosis Infection
    2004 527 citations Toru Mori, Mitsunori Sakatani et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masaji Okada Japan 21 1.0k 754 726 460 452 66 2.2k
Alfredo Salerno Italy 35 2.8k 2.7× 798 1.1× 768 1.1× 480 1.0× 311 0.7× 90 4.2k
Fabrizio Poccia Italy 37 3.1k 3.0× 541 0.7× 830 1.1× 532 1.2× 148 0.3× 92 4.3k
Vincent Kindler Switzerland 29 1.8k 1.7× 652 0.9× 743 1.0× 1.1k 2.3× 430 1.0× 64 3.9k
Fritz von Weizsäcker Germany 29 710 0.7× 445 0.6× 1.9k 2.6× 614 1.3× 147 0.3× 64 3.2k
Bernhard Odermatt Switzerland 31 954 0.9× 193 0.3× 365 0.5× 557 1.2× 177 0.4× 67 2.6k
Fang Shen United States 15 2.4k 2.4× 1.0k 1.4× 923 1.3× 547 1.2× 185 0.4× 20 3.6k
Noriyuki Fujikado Japan 12 1.4k 1.4× 355 0.5× 340 0.5× 465 1.0× 100 0.2× 14 2.2k
Verónica García Argentina 25 1.9k 1.8× 732 1.0× 707 1.0× 402 0.9× 197 0.4× 70 2.9k
Ryu Yoshida Japan 21 752 0.7× 237 0.3× 533 0.7× 274 0.6× 250 0.6× 60 1.8k
Stephan D. Gadola United Kingdom 25 2.6k 2.5× 274 0.4× 730 1.0× 332 0.7× 325 0.7× 48 3.4k

Countries citing papers authored by Masaji Okada

Since Specialization
Citations

This map shows the geographic impact of Masaji Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaji Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaji Okada more than expected).

Fields of papers citing papers by Masaji Okada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaji Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaji Okada. The network helps show where Masaji Okada may publish in the future.

Co-authorship network of co-authors of Masaji Okada

This figure shows the co-authorship network connecting the top 25 collaborators of Masaji Okada. A scholar is included among the top collaborators of Masaji Okada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaji Okada. Masaji Okada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goss, Glenwood, Gail Darling, Francesco Perrone, et al.. (2025). LBA3: Sites of relapse and subsequent therapy in the BR.31 phase III study of durvalumab vs placebo in resected stage IB-IIIA NSCLC. Journal of Thoracic Oncology. 20(3). S98–S99.
2.
Kubo, Keitaro, et al.. (2018). Is the stiffness of human muscle and tendon structures related to muscle fiber composition in vivo?. The Journal of Sports Medicine and Physical Fitness. 58(5). 622–629. 2 indexed citations
3.
Sakurada, Shinsaku, Takahiro Tanaka, Junko Tanuma, et al.. (2013). Potential Function of Granulysin, Other Related Effector Molecules and Lymphocyte Subsets in Patients with TB and HIV/TB Coinfection. International Journal of Medical Sciences. 10(8). 1003–1014. 18 indexed citations
4.
Kita, Yoko, Satomi Hashimoto, Toshihiro Nakajima, et al.. (2013). Novel therapeutic vaccines [(HSP65 + IL-12)DNA-, granulysin- and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapy. Human Vaccines & Immunotherapeutics. 9(3). 526–533. 15 indexed citations
5.
Okada, Masaji, Yoko Kita, Noriko Kanamaru, et al.. (2011). Anti-IL-6 Receptor Antibody Causes Less Promotion of Tuberculosis Infection than Anti-TNF- Antibody in Mice. SHILAP Revista de lepidopterología. 2011. 1–9. 20 indexed citations
6.
Hayashi, Seiji, Yusuke Oji, Masanori Kitaichi, et al.. (2011). Low Wilms’ Tumor Gene Expression in Tumor Tissues Predicts Poor Prognosis in Patients with Non-Small-Cell Lung Cancer. Cancer Investigation. 30(2). 165–171. 10 indexed citations
7.
Okada, Masaji & Yoko Kita. (2010). [Anti-tuberculosis immunity by cytotoxic T cells * granulysin and the development of novel vaccines (HSP-65 DNA+IL-12 DNA)].. PubMed. 85(6). 531–8. 3 indexed citations
8.
Okada, Masaji & Yoko Kita. (2010). Tuberculosis vaccine development :The development of a novel (preclinical) DNA vaccine. Human Vaccines. 6(4). 297–308. 18 indexed citations
9.
Kuwamura, Mitsuru, Mitsuaki Moriyama, Masafumi Mukamoto, et al.. (2008). Neuritogenic Effects of T Cell-Derived IL-3 on Mouse Splenic Sympathetic Neurons In Vivo. The Journal of Immunology. 180(6). 4227–4234. 7 indexed citations
10.
11.
12.
Mori, Toru, Mitsunori Sakatani, Fumio Yamagishi, et al.. (2004). Specific Detection of Tuberculosis Infection. American Journal of Respiratory and Critical Care Medicine. 170(1). 59–64. 527 indexed citations breakdown →
13.
Yoshida, Shigeto, Daisuke Kondoh, Hiroyuki Matsuoka, et al.. (2003). Baculovirus virions displaying Plasmodium berghei circumsporozoite protein protect mice against malaria sporozoite infection. Virology. 316(1). 161–170. 55 indexed citations
14.
Iwasaki, Teruo, Manabu Nakashima, Takeshi Watanabe, et al.. (2000). Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1. International Journal of Cancer. 89(6). 488–493. 67 indexed citations
15.
Kishimoto, Susumu, et al.. (1990). The in vivo Anti‐tumor Effect of Human Recombinant Interleukin‐6. Japanese Journal of Cancer Research. 81(10). 1032–1038. 32 indexed citations
16.
17.
Shirasaka, Takuma, Ichiro Kawase, Masaji Okada, et al.. (1989). Augmentative effect ofNocardia rubra cell-wall skeleton on the induction of human lymphokine-activated killer (LAK) cells by the production of LAK cell helper factor(s). Cancer Immunology Immunotherapy. 30(4). 195–204. 1 indexed citations
18.
Okada, Masaji, Masanori Kitahara, S. Kishimoto, et al.. (1988). IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells.. The Journal of Immunology. 141(5). 1543–1549. 315 indexed citations
19.
Okada, Masaji, Naoko Sakaguchi, Norio Yoshimura, et al.. (1983). B cell growth factors and B cell differentiation factor from human T hybridomas. Two distinct kinds of B cell growth factor and their synergism in B cell proliferation.. The Journal of Experimental Medicine. 157(2). 583–590. 150 indexed citations
20.
Igarashi, T., Masaji Okada, S Kishimoto, & Yasuhisa Yamamura. (1975). The relation between the T cells responsible for cell-mediated cytotoxic killing of mastocytoma cells and the helper-cell effect.. PubMed Central. 28(1). 37–47. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alfredo Salerno Breakdown of academic impact, for papers by Fabrizio Poccia Breakdown of academic impact, for papers by Vincent Kindler Breakdown of academic impact, for papers by Fritz von Weizsäcker Breakdown of academic impact, for papers by Bernhard Odermatt Breakdown of academic impact, for papers by Fang Shen Breakdown of academic impact, for papers by Noriyuki Fujikado Breakdown of academic impact, for papers by Verónica García Breakdown of academic impact, for papers by Ryu Yoshida Breakdown of academic impact, for papers by Stephan D. Gadola
Rankless by CCL
2026